 | NnBU (NNBU) |
NnBU is a revolutionary healthcare device that provides postnatal treatments after caesarean-section deliveries backed by blockchain technology
WhitepaperImportant By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.
What is NnBU
NnBU device, situated in hospitals and clinics, used straight after the baby is born, seeks to reproduce part of these positive stresses in a controlled manner. This gives the baby the benefits of a natural birth, even though they were born by Caesarean-section.
The device applies a controlled pressure to the baby in different sections of the torso for a predetermined period while also holding the baby in a warm, comfortable environment. Also, because most C-section babies are asleep when delivered, the NnBU device also focuses lighton the babys fontanel in order to create a comfortable waking process for the newborn baby.
NnBU Roadmap
Development of the medical device in cooperation with Fraunhofer IPA;
Device certification by DMTpe GmbH;
Global intellectual property protection;
Development of the medical device in cooperation with Fraunhofer IPA;
Device certification by DMTpe GmbH;
Global intellectual property protection;
Germany, Austria & Switzerland (DACH) market entry;
Investors pay-out in Y1;
France & Benelux market entry;
Brasil & Argentina market entry;
Mexico market entry;
US and Canada market entry; Investors pay-out in Y2;
Other European countries (UK, Italy, Portugal, Spain, Poland, Hungary, Slovakia, Czech Republic) market entry;
Turkey and Egypt market entry.
Investors pay-out in Y3;
China, India and Indonesia market entry.
Investors pay-out in Y4;
Investors pay-out in Y5;
Token Sale Dates
Presale Period
ICO
Token Allocation
Funding Details
Token distribution
75% - Token sale
25% - Pre-sale
Funds allocation
62% - Research and Development; Capital Expenditure for the Assembly and Testing facility;
12% - Cash Reserve
12% - Other operating expenses during the development period
7% - Negative cash flow; Investors pay-out during the first year of commercial operations EUR 1,115,000
7% - Market entry costs
Token Price and Payment Options
Dividends
Token holders will get a percentage of revenues.
Project team
Social media
Twitter
Telegram
LinkedInIndustries
